Atlas Trials

BRCA2 Mutation

58 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRCA2 Mutation

RecordFirmDate
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients (NCT05410951)European Institute of Oncology2022-05-16
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma (NCT05537844)Liz-Anne Lewsley2021-10-27
FaCT Trial (Facilitated Cascade Testing Trial) (NCT04613440)Weill Medical College of Cornell University2021-07-21
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening (NCT04273542)Centre Jean Perrin2021-05-31
BrUOG 390: Neoadjuvant Treatment With Talazoparib (NCT04598321)Brown University2021-03-29
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042)General Oncology, Inc.2021-01-13
Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing (NCT04683068)European Institute of Oncology2021-01-10
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer (NCT04651920)Lei Li2020-11-26
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071)Xiaoxiang Chen2020-11-06
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952)Xiaoxiang Chen2020-10-28
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer (NCT03685331)Abramson Cancer Center at Penn Medicine2020-10-15
Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction (NCT04108117)Severance Hospital2020-05-14
Genetic Education in BRCA Families (NCT03544983)Georgetown University2020-05-01
Evaluating Cascade Communication Methods (NCT04428736)University of Pennsylvania2020-02-19
Prostate Cancer Genetic Risk Evaluation and Screening Study (NCT05129605)Massachusetts General Hospital2020-02-12
Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM) (NCT04866992)University of Texas Southwestern Medical Center2020-02-01
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer (NCT04190667)Lei Li2019-12-07
Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy (NCT04151368)University Health Network, Toronto2019-11-01
BRCA1/2 Flu Vaccine (NCT04499534)Abramson Cancer Center at Penn Medicine2019-10-28
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (NCT04055038)Blokhin's Russian Cancer Research Center2019-09-01
Registry of Subjects at Risk of Pancreatic Cancer (NCT04095195)Associazione Italiana per lo Studio del Pancreas2019-08-20
Health After eaRly Menopause Due to Oophorectomy (NCT03835793)The Netherlands Cancer Institute2019-02-11
Functional Analysis of BRCAness (NCT04780945)Leiden University Medical Center2019-01-21
The Genetic Education for Men Trial: Web-Based Education vs. Standard Care (NCT02957981)Georgetown University2018-10-01
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing (NCT03475979)Seoul National University Hospital2018-05-01
Decision Support for BRCA Testing in Ethnically Diverse Women (NCT03470402)Columbia University2017-12-13
BRCA Founder OutReach (BFOR) Study (NCT03351803)Memorial Sloan Kettering Cancer Center2017-11-10
Depression and Body Image Distress Following Mastectomy With Reconstruction (NCT03428399)Massachusetts General Hospital2017-10-12
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients (NCT03032614)The University of Texas Health Science Center at San Antonio2017-09-30
Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309)University Health Network, Toronto2017-08-03
IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA) (NCT04012229)Centre Hospitalier Universitaire de Besancon2017-07-28
Management of Women With BRCA1/2 Mutation (NCT03211611)University Hospital, Montpellier2017-04-01
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer (NCT03684733)Royal Marsden NHS Foundation Trust2017-03-13
Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance (NCT02974842)nVision Medical2016-11-02
Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers (NCT03495609)University Hospital, Ghent2016-02-17
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction (NCT01591746)Mayo Clinic2012-08-01
Endocrine Disruptors and Life STILe in Breast Cancer Development (NCT05748353)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2012-01-01
3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women (NCT01409226)NYU Langone Health2009-08-01

Track BRCA2 Mutation automatically

Every clearance here is in the API, with alerts when new ones post.